Instem plc Appointment of VP Global Sales

TIDMINS

Instem plc

09 October 2013

RNS Reach

9 October 2013

Instem plc

("Instem", the "Company" or the "Group")

Appointment of VP Global Sales

Instem plc (AIM: INS.L), a leading provider of IT applications to the global early development healthcare market, announces that it has appointed Edward Lorenti as its new Vice President of Global Sales.

Based in the US, Mr Lorenti has responsibility for global sales, bringing together the current teams of sales professionals for each business unit and the strong existing account relationships. His focus will be on growing market share in existing segments and opening up new areas with the Company's broadening product set. The new position will strengthen Instem's ability to address continued global demand for integrated solutions, as the Company continues its organic and acquisitive expansion within the early development market.

Mr Lorenti has over 24 years' sales and business development experience within organisations providing enterprise software products and solutions in the life sciences industry. His extensive sales and sales management experience has been demonstrated with both mature and emerging products introduced both organically and through acquisitions.

Mr. Lorenti joins Instem from the technology solutions division of Accenture, which he joined in 2012 through its acquisition of Octagon Research Solutions where he was responsible for the enterprise content management and submission software platform serving pharmaceutical and biotechnology clients worldwide.

Phil Reason, CEO of Instem plc, commented: "We are delighted that Ed has joined Instem in this strategically important role at this stage of the Company's evolution. The appointment of a senior sales manager with vast international experience in the sector is key to aligning our global sales organisation across Instem's four distinct product ranges. We look forward to working with Ed in delivering further business success, as we meet the increasing needs of our clients to purchase integrated software solutions."

For further information, please contact:

 
 Instem plc                  +44 (0) 1785 825 600 
 Phil Reason, CEO 
 Nigel Goldsmith, CFO 
 
 N+1 Singer (Nominated 
  Adviser & Broker)          +44 (0) 20 7496 3000 
 Richard Lindley / Aubrey 
  Powell 
 
 Newgate Threadneedle        +44 (0) 20 7653 9850 
 Fiona Conroy 
 Caroline Evans-Jones 
 Jasper Randall

About Instem plc

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are used by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's established portfolio of software solutions increases client productivity in drug development by automating study-related processes and enabling high integrity data sharing. The product suite also offers the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com or its investor centre http://investors.instem.com/

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAMPBMTMBMMTRJ

Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024